Due to the hierarchical order of WHO-HAEM5 if the criteria for MDS with low blasts and 5q deletion are fulfilled, cases should be classified as such, even if a SF3B1 mutation was identified [1]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.